(Q46895629)

English

Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol).

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

0 references

author name string

Monika Dvoráková

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Daniela Jezová

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Pavol Blazícek

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Jana Trebatická

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Igor Skodácek

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Ján Suba

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Waczulíková Iveta

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Peter Rohdewald

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Zdenka Duracková

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Nutritional Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

3-4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

151-157

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

Adrenomedullary function during cognitive testing in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Omega-3 fatty acid status in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Attention-deficit/hyperactivity disorder: a selective overview

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Performance on a visual sustained attention and discrimination task is associated with urinary excretion of norepineprhine metabolite in children with attention-deficit/hyperactivity disorder (AD/HD).

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Increased Levels of Ethane, A Non-invasive Marker of n-3 Fatty Acid Oxidation, in Breath of Children with Attention Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701565443

21 January 2018

Identifiers

10.1080/09513590701565443

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18019397

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46895629&oldid=2171326428"